EVerZom

EVerZom is an exosome biotech company developing exosome therapeutics in digestive tissue healing, fistula and organ regeneration. Founded in 2019, EverZom stands among the pioneers in exosome-based therapies, a significant revolution in the current therapeutic landscape of gene and cell therapies. Exosomes are biological nanoparticles secreted by cells that currently raise growing interest within the pharmaceutical industry due to their potent role in intercellular communication. They hold promising properties for treating a wide range of diseases with high unmet medical need.